United States Prophylactic Human Vaccine Market Report 2017

Name: United States Prophylactic Human Vaccine Market Report 2017
Brand: QYResearch
SKU: UD528949E46EN
Price: 3800 USD
Availability: InStock

December 2017 | 101 pages | ID: UD528949E46EN
QYResearch

US$ 3,800.00

E-mail Delivery (PDF)

Download PDF Leaflet

Wire Transfer

Checkout Later

Need Help? Ask a Question

In this report, the United States Prophylactic Human Vaccine market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report splits the United States market into seven regions:

The West
Southwest
The Middle Atlantic
New England
The South
The Midwest
with sales (volume), revenue (value), market share and growth rate of Prophylactic Human Vaccine in these regions, from 2012 to 2022 (forecast).

United States Prophylactic Human Vaccine market competition by top manufacturers/players, with Prophylactic Human Vaccine sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including

GSK
Biovac
McKesson Medical
Merck
Merial
Zoetis
Sanofi

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into

Inactivated Vaccine
Attenuated Vaccine
Others

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including

Hospital
Scientific Research
Others

If you have any special requirements, please let us know and we will offer you the report as you want.

United States Prophylactic Human Vaccine Market Report 2017

1 PROPHYLACTIC HUMAN VACCINE OVERVIEW

1.1 Product Overview and Scope of Prophylactic Human Vaccine
1.2 Classification of Prophylactic Human Vaccine by Product Category
  1.2.1 United States Prophylactic Human Vaccine Market Size (Sales Volume) Comparison by Type (2012-2022)
  1.2.2 United States Prophylactic Human Vaccine Market Size (Sales Volume) Market Share by Type (Product Category) in 2016
  1.2.3 Inactivated Vaccine
  1.2.4 Attenuated Vaccine
  1.2.5 Others
1.3 United States Prophylactic Human Vaccine Market by Application/End Users
  1.3.1 United States Prophylactic Human Vaccine Market Size (Consumption) and Market Share Comparison by Application (2012-2022)
  1.3.2 Hospital
  1.3.3 Scientific Research
  1.3.4 Others
1.4 United States Prophylactic Human Vaccine Market by Region
  1.4.1 United States Prophylactic Human Vaccine Market Size (Value) Comparison by Region (2012-2022)
  1.4.2 The West Prophylactic Human Vaccine Status and Prospect (2012-2022)
  1.4.3 Southwest Prophylactic Human Vaccine Status and Prospect (2012-2022)
  1.4.4 The Middle Atlantic Prophylactic Human Vaccine Status and Prospect (2012-2022)
  1.4.5 New England Prophylactic Human Vaccine Status and Prospect (2012-2022)
  1.4.6 The South Prophylactic Human Vaccine Status and Prospect (2012-2022)
  1.4.7 The Midwest Prophylactic Human Vaccine Status and Prospect (2012-2022)
1.5 United States Market Size (Value and Volume) of Prophylactic Human Vaccine (2012-2022)
  1.5.1 United States Prophylactic Human Vaccine Sales and Growth Rate (2012-2022)
  1.5.2 United States Prophylactic Human Vaccine Revenue and Growth Rate (2012-2022)

2 UNITED STATES PROPHYLACTIC HUMAN VACCINE MARKET COMPETITION BY PLAYERS/SUPPLIERS

2.1 United States Prophylactic Human Vaccine Sales and Market Share of Key Players/Suppliers (2012-2017)
2.2 United States Prophylactic Human Vaccine Revenue and Share by Players/Suppliers (2012-2017)
2.3 United States Prophylactic Human Vaccine Average Price by Players/Suppliers (2012-2017)
2.4 United States Prophylactic Human Vaccine Market Competitive Situation and Trends
  2.4.1 United States Prophylactic Human Vaccine Market Concentration Rate
  2.4.2 United States Prophylactic Human Vaccine Market Share of Top 3 and Top 5 Players/Suppliers
  2.4.3 Mergers & Acquisitions, Expansion in United States Market
2.5 United States Players/Suppliers Prophylactic Human Vaccine Manufacturing Base Distribution, Sales Area, Product Type

3 UNITED STATES PROPHYLACTIC HUMAN VACCINE SALES (VOLUME) AND REVENUE (VALUE) BY REGION (2012-2017)

3.1 United States Prophylactic Human Vaccine Sales and Market Share by Region (2012-2017)
3.2 United States Prophylactic Human Vaccine Revenue and Market Share by Region (2012-2017)
3.3 United States Prophylactic Human Vaccine Price by Region (2012-2017)

4 UNITED STATES PROPHYLACTIC HUMAN VACCINE SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (PRODUCT CATEGORY) (2012-2017)

4.1 United States Prophylactic Human Vaccine Sales and Market Share by Type (Product Category) (2012-2017)
4.2 United States Prophylactic Human Vaccine Revenue and Market Share by Type (2012-2017)
4.3 United States Prophylactic Human Vaccine Price by Type (2012-2017)
4.4 United States Prophylactic Human Vaccine Sales Growth Rate by Type (2012-2017)

5 UNITED STATES PROPHYLACTIC HUMAN VACCINE SALES (VOLUME) BY APPLICATION (2012-2017)

5.1 United States Prophylactic Human Vaccine Sales and Market Share by Application (2012-2017)
5.2 United States Prophylactic Human Vaccine Sales Growth Rate by Application (2012-2017)
5.3 Market Drivers and Opportunities

6 UNITED STATES PROPHYLACTIC HUMAN VACCINE PLAYERS/SUPPLIERS PROFILES AND SALES DATA

6.1 GSK
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Prophylactic Human Vaccine Product Category, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 GSK Prophylactic Human Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
  6.1.4 Main Business/Business Overview
6.2 Biovac
  6.2.2 Prophylactic Human Vaccine Product Category, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 Biovac Prophylactic Human Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
  6.2.4 Main Business/Business Overview
6.3 McKesson Medical
  6.3.2 Prophylactic Human Vaccine Product Category, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 McKesson Medical Prophylactic Human Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
  6.3.4 Main Business/Business Overview
6.4 Merck
  6.4.2 Prophylactic Human Vaccine Product Category, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 Merck Prophylactic Human Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
  6.4.4 Main Business/Business Overview
6.5 Merial
  6.5.2 Prophylactic Human Vaccine Product Category, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 Merial Prophylactic Human Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
  6.5.4 Main Business/Business Overview
6.6 Zoetis
  6.6.2 Prophylactic Human Vaccine Product Category, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 Zoetis Prophylactic Human Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
  6.6.4 Main Business/Business Overview
6.7 Sanofi
  6.7.2 Prophylactic Human Vaccine Product Category, Application and Specification
    6.7.2.1 Product A
    6.7.2.2 Product B
  6.7.3 Sanofi Prophylactic Human Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
  6.7.4 Main Business/Business Overview

7 PROPHYLACTIC HUMAN VACCINE MANUFACTURING COST ANALYSIS

7.1 Prophylactic Human Vaccine Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Prophylactic Human Vaccine

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Prophylactic Human Vaccine Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Prophylactic Human Vaccine Major Manufacturers in 2016
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 UNITED STATES PROPHYLACTIC HUMAN VACCINE MARKET SIZE (VALUE AND VOLUME) FORECAST (2017-2022)

11.1 United States Prophylactic Human Vaccine Sales Volume, Revenue Forecast (2017-2022)
11.2 United States Prophylactic Human Vaccine Sales Volume Forecast by Type (2017-2022)
11.3 United States Prophylactic Human Vaccine Sales Volume Forecast by Application (2017-2022)
11.4 United States Prophylactic Human Vaccine Sales Volume Forecast by Region (2017-2022)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer

The report requires updating with new data and is sent in 2-3 business days after order is placed.

LIST OF TABLES AND FIGURES

Figure Product Picture of Prophylactic Human Vaccine
Figure United States Prophylactic Human Vaccine Market Size (K Pcs) by Type (2012-2022)
Figure United States Prophylactic Human Vaccine Sales Volume Market Share by Type (Product Category) in 2016
Figure Inactivated Vaccine Product Picture
Figure Attenuated Vaccine Product Picture
Figure Others Product Picture
Figure United States Prophylactic Human Vaccine Market Size (K Pcs) by Application (2012-2022)
Figure United States Sales Market Share of Prophylactic Human Vaccine by Application in 2016
Figure Hospital Examples
Table Key Downstream Customer in Hospital
Figure Scientific Research Examples
Table Key Downstream Customer in Scientific Research
Figure Others Examples
Table Key Downstream Customer in Others
Figure United States Prophylactic Human Vaccine Market Size (Million USD) by Region (2012-2022)
Figure The West Prophylactic Human Vaccine Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southwest Prophylactic Human Vaccine Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Middle Atlantic Prophylactic Human Vaccine Revenue (Million USD) and Growth Rate (2012-2022)
Figure New England Prophylactic Human Vaccine Revenue (Million USD) and Growth Rate (2012-2022)
Figure The South of US Prophylactic Human Vaccine Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Midwest Prophylactic Human Vaccine Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Prophylactic Human Vaccine Sales (K Pcs) and Growth Rate (2012-2022)
Figure United States Prophylactic Human Vaccine Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Prophylactic Human Vaccine Market Major Players Product Sales Volume (K Pcs) (2012-2017)
Table United States Prophylactic Human Vaccine Sales (K Pcs) of Key Players/Suppliers (2012-2017)
Table United States Prophylactic Human Vaccine Sales Share by Players/Suppliers (2012-2017)
Figure 2016 United States Prophylactic Human Vaccine Sales Share by Players/Suppliers
Figure 2017 United States Prophylactic Human Vaccine Sales Share by Players/Suppliers
Figure United States Prophylactic Human Vaccine Market Major Players Product Revenue (Million USD) (2012-2017)
Table United States Prophylactic Human Vaccine Revenue (Million USD) by Players/Suppliers (2012-2017)
Table United States Prophylactic Human Vaccine Revenue Share by Players/Suppliers (2012-2017)
Figure 2016 United States Prophylactic Human Vaccine Revenue Share by Players/Suppliers
Figure 2017 United States Prophylactic Human Vaccine Revenue Share by Players/Suppliers
Table United States Market Prophylactic Human Vaccine Average Price (USD/Pcs) of Key Players/Suppliers (2012-2017)
Figure United States Market Prophylactic Human Vaccine Average Price (USD/Pcs) of Key Players/Suppliers in 2016
Figure United States Prophylactic Human Vaccine Market Share of Top 3 Players/Suppliers
Figure United States Prophylactic Human Vaccine Market Share of Top 5 Players/Suppliers
Table United States Players/Suppliers Prophylactic Human Vaccine Manufacturing Base Distribution and Sales Area
Table United States Players/Suppliers Prophylactic Human Vaccine Product Category
Table United States Prophylactic Human Vaccine Sales (K Pcs) by Region (2012-2017)
Table United States Prophylactic Human Vaccine Sales Share by Region (2012-2017)
Figure United States Prophylactic Human Vaccine Sales Share by Region (2012-2017)
Figure United States Prophylactic Human Vaccine Sales Market Share by Region in 2016
Table United States Prophylactic Human Vaccine Revenue (Million USD) and Market Share by Region (2012-2017)
Table United States Prophylactic Human Vaccine Revenue Share by Region (2012-2017)
Figure United States Prophylactic Human Vaccine Revenue Market Share by Region (2012-2017)
Figure United States Prophylactic Human Vaccine Revenue Market Share by Region in 2016
Table United States Prophylactic Human Vaccine Price (USD/Pcs) by Region (2012-2017)
Table United States Prophylactic Human Vaccine Sales (K Pcs) by Type (2012-2017)
Table United States Prophylactic Human Vaccine Sales Share by Type (2012-2017)
Figure United States Prophylactic Human Vaccine Sales Share by Type (2012-2017)
Figure United States Prophylactic Human Vaccine Sales Market Share by Type in 2016
Table United States Prophylactic Human Vaccine Revenue (Million USD) and Market Share by Type (2012-2017)
Table United States Prophylactic Human Vaccine Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Prophylactic Human Vaccine by Type (2012-2017)
Figure Revenue Market Share of Prophylactic Human Vaccine by Type in 2016
Table United States Prophylactic Human Vaccine Price (USD/Pcs) by Types (2012-2017)
Figure United States Prophylactic Human Vaccine Sales Growth Rate by Type (2012-2017)
Table United States Prophylactic Human Vaccine Sales (K Pcs) by Application (2012-2017)
Table United States Prophylactic Human Vaccine Sales Market Share by Application (2012-2017)
Figure United States Prophylactic Human Vaccine Sales Market Share by Application (2012-2017)
Figure United States Prophylactic Human Vaccine Sales Market Share by Application in 2016
Table United States Prophylactic Human Vaccine Sales Growth Rate by Application (2012-2017)
Figure United States Prophylactic Human Vaccine Sales Growth Rate by Application (2012-2017)
Table GSK Basic Information List
Table GSK Prophylactic Human Vaccine Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure GSK Prophylactic Human Vaccine Sales Growth Rate (2012-2017)
Figure GSK Prophylactic Human Vaccine Sales Market Share in United States (2012-2017)
Figure GSK Prophylactic Human Vaccine Revenue Market Share in United States (2012-2017)
Table Biovac Basic Information List
Table Biovac Prophylactic Human Vaccine Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Biovac Prophylactic Human Vaccine Sales Growth Rate (2012-2017)
Figure Biovac Prophylactic Human Vaccine Sales Market Share in United States (2012-2017)
Figure Biovac Prophylactic Human Vaccine Revenue Market Share in United States (2012-2017)
Table McKesson Medical Basic Information List
Table McKesson Medical Prophylactic Human Vaccine Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure McKesson Medical Prophylactic Human Vaccine Sales Growth Rate (2012-2017)
Figure McKesson Medical Prophylactic Human Vaccine Sales Market Share in United States (2012-2017)
Figure McKesson Medical Prophylactic Human Vaccine Revenue Market Share in United States (2012-2017)
Table Merck Basic Information List
Table Merck Prophylactic Human Vaccine Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Merck Prophylactic Human Vaccine Sales Growth Rate (2012-2017)
Figure Merck Prophylactic Human Vaccine Sales Market Share in United States (2012-2017)
Figure Merck Prophylactic Human Vaccine Revenue Market Share in United States (2012-2017)
Table Merial Basic Information List
Table Merial Prophylactic Human Vaccine Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Merial Prophylactic Human Vaccine Sales Growth Rate (2012-2017)
Figure Merial Prophylactic Human Vaccine Sales Market Share in United States (2012-2017)
Figure Merial Prophylactic Human Vaccine Revenue Market Share in United States (2012-2017)
Table Zoetis Basic Information List
Table Zoetis Prophylactic Human Vaccine Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Zoetis Prophylactic Human Vaccine Sales Growth Rate (2012-2017)
Figure Zoetis Prophylactic Human Vaccine Sales Market Share in United States (2012-2017)
Figure Zoetis Prophylactic Human Vaccine Revenue Market Share in United States (2012-2017)
Table Sanofi Basic Information List
Table Sanofi Prophylactic Human Vaccine Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Sanofi Prophylactic Human Vaccine Sales Growth Rate (2012-2017)
Figure Sanofi Prophylactic Human Vaccine Sales Market Share in United States (2012-2017)
Figure Sanofi Prophylactic Human Vaccine Revenue Market Share in United States (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Prophylactic Human Vaccine
Figure Manufacturing Process Analysis of Prophylactic Human Vaccine
Figure Prophylactic Human Vaccine Industrial Chain Analysis
Table Raw Materials Sources of Prophylactic Human Vaccine Major Players/Suppliers in 2016
Table Major Buyers of Prophylactic Human Vaccine
Table Distributors/Traders List
Figure United States Prophylactic Human Vaccine Sales Volume (K Pcs) and Growth Rate Forecast (2017-2022)
Figure United States Prophylactic Human Vaccine Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure United States Prophylactic Human Vaccine Price (USD/Pcs) Trend Forecast (2017-2022)
Table United States Prophylactic Human Vaccine Sales Volume (K Pcs) Forecast by Type (2017-2022)
Figure United States Prophylactic Human Vaccine Sales Volume (K Pcs) Forecast by Type (2017-2022)
Figure United States Prophylactic Human Vaccine Sales Volume (K Pcs) Forecast by Type in 2022
Table United States Prophylactic Human Vaccine Sales Volume (K Pcs) Forecast by Application (2017-2022)
Figure United States Prophylactic Human Vaccine Sales Volume (K Pcs) Forecast by Application (2017-2022)
Figure United States Prophylactic Human Vaccine Sales Volume (K Pcs) Forecast by Application in 2022
Table United States Prophylactic Human Vaccine Sales Volume (K Pcs) Forecast by Region (2017-2022)
Table United States Prophylactic Human Vaccine Sales Volume Share Forecast by Region (2017-2022)
Figure United States Prophylactic Human Vaccine Sales Volume Share Forecast by Region (2017-2022)
Figure United States Prophylactic Human Vaccine Sales Volume Share Forecast by Region in 2022
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

United States Prophylactic Human Vaccine Market Report 2017

More Publications

Need Help?

Ask a Question

Market Reports